UPDATE 1-Roche Alzheimer's drug fails main goals in mid-stage study
July 16, 2014 at 13:52 PM EDT
* Signs of benefit at higher dose in milder patients (Adds comment from analyst, independent researcher, shares)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.